Business Standard

Canada clears world's first plant-based vaccine against Covid-19

The approval gives people who are hesitant to take currently available vaccines made by Pfizer Inc., AstraZeneca Plc and Moderna Inc. another option.

vaccination
Premium

Representative image

Kanoko Matsuyama | Bloomberg
The world’s first plant-derived Covid-19 vaccine was cleared for use in Canada, creating a novel immunization to combat the virus from a unit of Mitsubishi Chemical Holdings Corp. and Philip Morris International. 
 
The vaccine named Covifenz was jointly developed by Medicago Inc., a biopharma company owned by Mitsubishi Chemical and Philip Morris and based in Quebec City, and GlaxoSmithKline Plc. It will be available for adults aged 18 to 64, Medicago and Glaxo said in a statement Thursday. 

The approval gives people who are hesitant to take currently available vaccines made by Pfizer Inc., AstraZeneca Plc and Moderna Inc. another option.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 25 2022 | 10:06 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com